Clinical trial
Efficacy and Safety of Jaktinib in Newly Diagnosed Myelofibrosis: A Multicenter, Prospective, Real-World Observational Study
NCT07925632 is registered in ClinicalTrials.gov with Affiliated Hospital of Nantong University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Jaktinib in Newly Diagnosed Myelofibrosis: A Multicenter, Prospective, Real-World Observational Study
- Lead sponsor
- Affiliated Hospital of Nantong University
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- November 10, 2026
- Completion date
- December 31, 2028
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
myeloproliferative neoplasms/myelofibrosis
Lead sponsor's other trials
Affiliated Hospital of Nantong University, most recent start first.
+91 more trials See the organization page
Similar trials
Same condition (Primary Myelofibrosis) and phase, most recent start first.
+72 more trials See the condition page